Nonoperative, Active Surveillance of Larger Malignant and Suspicious Thyroid Nodules
The Journal of Clinical Endocrinology & Metabolism · 2024
DOI: 10.1210/clinem/dgae082 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Benjamin Altshuler und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Thyroid Nodule, Thyroid Neoplasms, Watchful Waiting, Thyroid Cancer, Papillary. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Context
Active surveillance for papillary thyroid cancer (PTC) meeting criteria for surgical resection is uncommon. Which patients may prove reasonable candidates for this approach is not well defined.
Objective
This work aimed to examine the feasibility and safety of active surveillance for patients with known or suspected intrathyroidal PTC up to 4 cm in diameter.
Methods
A retrospective review was conducted of all consecutive patients who underwent nonoperative active surveillance of suspicious or malignant thyroid nodules over a 20-year period from 2001 to 2021. We included patients with an initial ultrasound–fine-needle aspiration confirming either (a) Bethesda 5 or 6 cytology or (b) a “suspicious” Afirma molecular test. The primary outcomes and measures included the rate of adverse oncologic outcomes (mortality and recurrence), as well as the cumulative incidence of size/volume growth.
Results
Sixty-nine patients were followed with active surveillance for 1 year or longer (average 55 months), with 26 patients (38%) having nodules 2 cm or larger. No patients were found to develop new-incident occurrence of lymph node or distant metastasis. One patient, however, demonstrated concern for progression to a dedifferentiated cancer on repeat core biopsy 17 years after initial start of nonoperative selection. A total of 21% of patients had an increase in maximum diameter more than 3 mm, while volume increase of 50% or greater was noted in 25% of patients. Thirteen patients ultimately underwent delayed (rescue) surgery, and no disease recurrence was noted after such treatment. Age and initial nodule size were not predictors of nodule growth.
Conclusion
These data expand consideration of active surveillance of PTC in select patients with intrathyroidal suspected malignancy greater than 1 cm in diameter. Rescue surgery, if required at a later time point, appears effective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
- Harvard Medical School, Boston, MA 02115, USA.
- Department of Surgery, Brigham and Women's Hospital, Boston, MA 02115, USA.
ORCID-Profile: Athanasios Bikas, Erik K Alexander
Zitieren
APA
Altshuler, B., Bikas, A., Pappa, T., Marqusee, E., Cho, N. L., Nehs, M. A., Liu, J. B., Doherty, G. M., Landa, I., Ahmadi, S., & Alexander, E. K. (2024). Nonoperative, Active Surveillance of Larger Malignant and Suspicious Thyroid Nodules. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae082
Vancouver
Altshuler B, Bikas A, Pappa T, Marqusee E, Cho NL, Nehs MA, et al. Nonoperative, Active Surveillance of Larger Malignant and Suspicious Thyroid Nodules. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae082
BibTeX
@article{Altshuler2024,
author = {Altshuler, Benjamin and Bikas, Athanasios and Pappa, Theodora and Marqusee, Ellen and Cho, Nancy L and Nehs, Matthew A and Liu, Jason B and Doherty, Gerard M and Landa, Iñigo and Ahmadi, Sara and Alexander, Erik K},
title = {Nonoperative, Active Surveillance of Larger Malignant and Suspicious Thyroid Nodules},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
doi = {10.1210/clinem/dgae082}
}
EUVIMED